Application of a Perineal Protection Device in Vacuum-assisted Births

November 1, 2022 updated by: University of Zurich

Application of a Perineal Protection Device in Vacuum-assisted Births: a Prospective Randomized Controlled Trial

Visible birth tears are common in vaginal births, especially in vacuum-assisted births. One aim of obstetrical work is to minimize such injuries by an adequate birth management , for example with a proper perineal support. The medical device "BabySlide®" was developed as an auxilliary device for perineal support and already evaluated in a multicenter randomized controlled trial in Schweden in pregnant women during vaginal birth. It could be seen, that the application of the device significantly reduced the rate of vagibal tears and low-grade perineal tearsin the intervention group (with application of the BabySlide®) in contrast to the controlo group (without application of the BabySlide®) by about 10%. In this study, solely 10% of births were ended by vacuum assistance. However, birth tears appear much more often in vacuum-assisted births than in normal spontaneous births. Therefore, the aim of this study is to evaluate the application of the device explicitly in vacuum-assisted births and to investigate if the application should be recommende in vacuum extractions in general in the future.

Study Overview

Status

Completed

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

194

Phase

  • Phase 3

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Zurich, Switzerland, 8091
        • University Hospital Zurich

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

16 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • Schwangere Frauen ab 18 Jahren
  • Schwangerschaftsalter ab 36+0 SSW bei Geburt
  • Einlingsschwangerschaft
  • Schädellage des Kindes bei Geburt
  • Anstreben einer Vaginalgeburt am USZ
  • Geburtsbeendigung per Vakuumextraktion (Saugglocke)
  • Schriftliche Einwilligung der teilnehmenden Person nach erfolgter Aufklärung (ausreichende Deutsch- bzw. Englischkenntnisse)

Exclusion Criteria:

  • - Geburtsbeendigung per Spontangeburt, Forcepsextraktion (Zange) oder Sectio caesarea (Kaiserschnitt)
  • Maternale Erkrankung des Bindegewebes (z.B. Kollagenosen)
  • Äusserliche fetale Fehlbildungen, die den Geburtsablauf und die Grössenverhältnisse von Kind zu Geburtskanal verändern
  • Intrauteriner Fruchttod des Kindes
  • Vaginale, perineale und/oder vulväre Voroperationen (ausser Naht von Geburtsverletzungen)
  • St.n. Beckenboden-Operation oder Inkontinenz-Operation
  • St.n. Infibulation
  • Anwendung des EPI-NO® Dammtrainers während der Schwangerschaft
  • Bekannte Allergien gegenüber einem der Inhaltsstoffe des BabySlide®

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: control
Active Comparator: intervention
Application of BabySlide during vacuum-assisted births for perineal protection

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
rate of vaginal tears
Time Frame: at day of birth
assessment of the rate of vaginal tears in the posterior compartment by inspection
at day of birth
rate of low-grade perineal tears
Time Frame: at day of birth
assessment of the rate of low-grade perineal tears by inspection
at day of birth

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
rate of high-grade perineal tears
Time Frame: at day of birth
assessment of the rate of high-grade perineal tears by inspection
at day of birth
Maternal adverse effects
Time Frame: within 1-4 days after birth
assessment of maternal adverse effects of the BabySlide by medical staff
within 1-4 days after birth
Fetal adverse effects
Time Frame: within 1-4 days after birth
assessment of fetal adverse effects of the BabySlide by medical staff
within 1-4 days after birth
Maternal comfort with the BabySlide
Time Frame: within 1-4 days after birth
Assessment of maternal comfort with the BabySlide by a questionnaire
within 1-4 days after birth
User abilitiy
Time Frame: directly after the procedure
Assessment of the user ability of the BabySlide by a questionnaire
directly after the procedure

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Nina Kimmich, Dr., University Hospital Zurich, Department od Obstetrics

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 1, 2020

Primary Completion (Actual)

September 30, 2022

Study Completion (Actual)

September 30, 2022

Study Registration Dates

First Submitted

April 21, 2020

First Submitted That Met QC Criteria

April 29, 2020

First Posted (Actual)

April 30, 2020

Study Record Updates

Last Update Posted (Actual)

November 2, 2022

Last Update Submitted That Met QC Criteria

November 1, 2022

Last Verified

November 1, 2022

More Information

Terms related to this study

Other Study ID Numbers

  • PeriProtectTrial

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

Undecided

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Perineal Tear

3
Subscribe